Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vaylet

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) programC Leduc, J P Merlio, B Besse, et al.
Revue Des Maladies Respiratoires|July 17, 2007
[Lung cancer in the elderly subject], G Albrand, E Biron, et al.
QJM : Monthly Journal of the Association of Physicians|March 22, 2013
Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 casesC Bernard, D Maucort-Boulch, L Varron, et al.
British Journal of Cancer|August 14, 2003
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)A Depierre, J L Lagrange, S Theobald, et al.
Bulletin Du Cancer|May 24, 2001
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]E Bardet, D Moro-Sibilot, T Le Chevalier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2001
[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]E Touboul, J L Lagrange, S Theobald, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) programC Leduc, J P Merlio, B Besse, et al.
Revue Des Maladies Respiratoires|July 17, 2007
[Lung cancer in the elderly subject], G Albrand, E Biron, et al.
QJM : Monthly Journal of the Association of Physicians|March 22, 2013
Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 casesC Bernard, D Maucort-Boulch, L Varron, et al.
British Journal of Cancer|August 14, 2003
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)A Depierre, J L Lagrange, S Theobald, et al.
Bulletin Du Cancer|May 24, 2001
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]E Bardet, D Moro-Sibilot, T Le Chevalier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2001
[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]E Touboul, J L Lagrange, S Theobald, et al.
Pageof 10